Global mRNA Vaccines & Therapeutics Market Analysis 2016-2020 and Forecast 2021-2026

Report Summary

Snapshot

The global mRNA Vaccines & Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of mRNA Vaccines & Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Standardization Of Cancer Treatment MRNA Vaccine
        Individualized Cancer Treatment MRNA Vaccine
        Infectious Disease Treatment MRNA Vaccine
        Infection Prevention MRNA Vaccine

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
        Argos Therapeutics
        AstraZeneca
        Bayer
        BioNTech
        Boehringer Ingelheim
        CRISPR Therapeutics
        CureVac
        eTheRNA immunotherapies
        Ethris
        GlaxoSmithKline Vaccines
        In-Cell-Art
        Intellia Therapeutics
        Janssen
        Kernal Biologics
        MaxCyte
        Moderna Therapeutics
        Novartis
        PhaseRx
        Precision NanoSystems
        RaNa Therapeutics

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
        Hospital
        Clinic
        Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
        North America (U.S., Canada, Mexico)
        Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
        Asia-Pacific (China, India, Japan, Southeast Asia etc.)
        South America (Brazil, Argentina etc.)
        Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of content

Table of Contents
Table of Contents
Table of Contents
1 Industry Overview
    1.1 mRNA Vaccines & Therapeutics Industry
                Figure mRNA Vaccines & Therapeutics Industry Chain Structure
        1.1.1 Overview
        1.1.2 Development of mRNA Vaccines & Therapeutics
    1.2 Market Segment
        1.2.1 Upstream
                Table Upstream Segment of mRNA Vaccines & Therapeutics
        1.2.2 Downstream
                Table Application Segment of mRNA Vaccines & Therapeutics
                Table Global mRNA Vaccines & Therapeutics Market 2016-2026, by Application, in USD Million
        1.2.3 COVID-19 Impact
    1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
    2.1 Policy
    2.2 Economics
    2.3 Sociology
    2.4 Technology
3 mRNA Vaccines & Therapeutics Market by Type
    3.1 By Type
        3.1.1 Standardization Of Cancer Treatment MRNA Vaccine
                Table Major Company List of Standardization Of Cancer Treatment MRNA Vaccine
        3.1.2 Individualized Cancer Treatment MRNA Vaccine
                Table Major Company List of Individualized Cancer Treatment MRNA Vaccine
        3.1.3 Infectious Disease Treatment MRNA Vaccine
                Table Major Company List of Infectious Disease Treatment MRNA Vaccine
        3.1.4 Infection Prevention MRNA Vaccine
                Table Major Company List of Infection Prevention MRNA Vaccine
    3.2 Market Size
                Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in USD Million
                Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in USD Million
                Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Type, in Volume
                Figure Global mRNA Vaccines & Therapeutics Market Growth 2016-2020, by Type, in Volume
    3.3 Market Forecast
                Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in USD Million
                Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
    4.1 Argos Therapeutics (Company Profile, Sales Data etc.)
        4.1.1 Argos Therapeutics Profile
                Table Argos Therapeutics Overview List
        4.1.2 Argos Therapeutics Products & Services
        4.1.3 Argos Therapeutics Business Operation Conditions
                Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.2 AstraZeneca (Company Profile, Sales Data etc.)
        4.2.1 AstraZeneca Profile
                Table AstraZeneca Overview List
        4.2.2 AstraZeneca Products & Services
        4.2.3 AstraZeneca Business Operation Conditions
                Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.3 Bayer (Company Profile, Sales Data etc.)
        4.3.1 Bayer Profile
                Table Bayer Overview List
        4.3.2 Bayer Products & Services
        4.3.3 Bayer Business Operation Conditions
                Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.4 BioNTech (Company Profile, Sales Data etc.)
        4.4.1 BioNTech Profile
                Table BioNTech Overview List
        4.4.2 BioNTech Products & Services
        4.4.3 BioNTech Business Operation Conditions
                Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.5 Boehringer Ingelheim (Company Profile, Sales Data etc.)
        4.5.1 Boehringer Ingelheim Profile
                Table Boehringer Ingelheim Overview List
        4.5.2 Boehringer Ingelheim Products & Services
        4.5.3 Boehringer Ingelheim Business Operation Conditions
                Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.6 CRISPR Therapeutics (Company Profile, Sales Data etc.)
        4.6.1 CRISPR Therapeutics Profile
                Table CRISPR Therapeutics Overview List
        4.6.2 CRISPR Therapeutics Products & Services
        4.6.3 CRISPR Therapeutics Business Operation Conditions
                Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.7 CureVac (Company Profile, Sales Data etc.)
        4.7.1 CureVac Profile
                Table CureVac Overview List
        4.7.2 CureVac Products & Services
        4.7.3 CureVac Business Operation Conditions
                Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.8 eTheRNA immunotherapies (Company Profile, Sales Data etc.)
        4.8.1 eTheRNA immunotherapies Profile
                Table eTheRNA immunotherapies Overview List
        4.8.2 eTheRNA immunotherapies Products & Services
        4.8.3 eTheRNA immunotherapies Business Operation Conditions
                Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.9 Ethris (Company Profile, Sales Data etc.)
        4.9.1 Ethris Profile
                Table Ethris Overview List
        4.9.2 Ethris Products & Services
        4.9.3 Ethris Business Operation Conditions
                Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.10 GlaxoSmithKline Vaccines (Company Profile, Sales Data etc.)
        4.10.1 GlaxoSmithKline Vaccines Profile
                Table GlaxoSmithKline Vaccines Overview List
        4.10.2 GlaxoSmithKline Vaccines Products & Services
        4.10.3 GlaxoSmithKline Vaccines Business Operation Conditions
                Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.11 In-Cell-Art (Company Profile, Sales Data etc.)
        4.11.1 In-Cell-Art Profile
                Table In-Cell-Art Overview List
        4.11.2 In-Cell-Art Products & Services
        4.11.3 In-Cell-Art Business Operation Conditions
                Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.12 Intellia Therapeutics (Company Profile, Sales Data etc.)
        4.12.1 Intellia Therapeutics Profile
                Table Intellia Therapeutics Overview List
        4.12.2 Intellia Therapeutics Products & Services
        4.12.3 Intellia Therapeutics Business Operation Conditions
                Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin)
    4.13 Janssen (Company Profile, Sales Data etc.)
        4.13.1 Janssen Profile
                Table Janssen Overview List
        4.13.2 Janssen Products & Services
        4.13.3 Janssen Business Operation Conditions
                Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.14 Kernal Biologics (Company Profile, Sales Data etc.)
        4.14.1 Kernal Biologics Profile
                Table Kernal Biologics Overview List
        4.14.2 Kernal Biologics Products & Services
        4.14.3 Kernal Biologics Business Operation Conditions
                Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin)
    4.15 MaxCyte (Company Profile, Sales Data etc.)
        4.15.1 MaxCyte Profile
                Table MaxCyte Overview List
        4.15.2 MaxCyte Products & Services
        4.15.3 MaxCyte Business Operation Conditions
                Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin)
    4.16 Moderna Therapeutics (Company Profile, Sales Data etc.)
        4.16.1 Moderna Therapeutics Profile
                Table Moderna Therapeutics Overview List
        4.16.2 Moderna Therapeutics Products & Services
        4.16.3 Moderna Therapeutics Business Operation Conditions
                Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin)
    4.17 Novartis (Company Profile, Sales Data etc.)
        4.17.1 Novartis Profile
                Table Novartis Overview List
        4.17.2 Novartis Products & Services
        4.17.3 Novartis Business Operation Conditions
                Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
    4.18 PhaseRx (Company Profile, Sales Data etc.)
        4.18.1 PhaseRx Profile
                Table PhaseRx Overview List
        4.18.2 PhaseRx Products & Services
        4.18.3 PhaseRx Business Operation Conditions
                Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin)
    4.19 Precision NanoSystems (Company Profile, Sales Data etc.)
        4.19.1 Precision NanoSystems Profile
                Table Precision NanoSystems Overview List
        4.19.2 Precision NanoSystems Products & Services
        4.19.3 Precision NanoSystems Business Operation Conditions
                Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin)
    4.20 RaNa Therapeutics (Company Profile, Sales Data etc.)
        4.20.1 RaNa Therapeutics Profile
                Table RaNa Therapeutics Overview List
        4.20.2 RaNa Therapeutics Products & Services
        4.20.3 RaNa Therapeutics Business Operation Conditions
                Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin)
5 Market Competition
    5.1 Company Competition
                Table Global mRNA Vaccines & Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
                Table Global mRNA Vaccines & Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
                Figure Global mRNA Vaccines & Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
                Table Global mRNA Vaccines & Therapeutics Sales Volume 2016-2020, by Company, in Volume
                Table Global mRNA Vaccines & Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
                Figure Global mRNA Vaccines & Therapeutics Sales Volume Share in 2020, by Company, in Volume
    5.2 Regional Market by Company
                Figure North America mRNA Vaccines & Therapeutics Market Concentration, in 2020
                Figure Europe mRNA Vaccines & Therapeutics Market Market Concentration, in 2020
                Figure Asia-Pacific mRNA Vaccines & Therapeutics MMarket Concentration, in 2020
                Figure South America mRNA Vaccines & Therapeutics Market Concentration, in 2020
                Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Concentration, in 2020
6 Demand by End Market
    6.1 Demand Situation
        6.1.1 Demand in Hospital
                Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in USD Million
                Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2016-2020, in Volume
        6.1.2 Demand in Clinic
                Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in USD Million
                Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2016-2020, in Volume
        6.1.3 Demand in Others
                Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in USD Million
                Figure mRNA Vaccines & Therapeutics Demand in Others, 2016-2020, in Volume
    6.2 Regional Demand Comparison
                Table Regional Demand Comparison List
                Table Major Application in Different Regions
    6.3 Demand Forecast
                Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
                Figure mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in USD Million
                Figure mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in USD Million
                Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2026, by Application, in Volume
                Table mRNA Vaccines & Therapeutics Market Growth 2021-2026, by Application, in Volume
                Table mRNA Vaccines & Therapeutics Market Share in 2026, by Application, in Volume
    6.4 Impact of the COVID-19 on the Demand
7 Region Operation
    7.1 Regional Production
                Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in USD Million
                Table mRNA Vaccines & Therapeutics Production 2016-2020, by Region, in Volume
    7.2 Regional Market
                Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in USD Million
                Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in USD Million
                Table Global mRNA Vaccines & Therapeutics Market 2016-2020, by Region, in Volume
                Table Global mRNA Vaccines & Therapeutics Market Share 2016-2020, by Region, in Volume
    7.3 by Region
        7.3.1 North America
            7.3.1.1 Overview
                Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
                Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
            7.3.1.2 by Country (U.S., Canada, Mexico)
                Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
                Table North America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
        7.3.2 Europe
            7.3.2.1 Overview
                Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
                Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
            7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
                Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
                Table Europe mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
        7.3.3 Asia-Pacific
            7.3.3.1 Overview
                Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
                Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
            7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
                Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
                Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in Volume
        7.3.4 South America
            7.3.4.1 Overview
                Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in USD Million
                Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2016-2020, in Volume
            7.3.4.2 by Country (Brazil, Argentina etc.)
                Table South America mRNA Vaccines & Therapeutics Market Size 2016-2020, by Country, in USD Million
                Table South America mRNA Vaccines & Therape